Artificial Intelligence in Diagnostics Market Analysis 2034
Global Artificial Intelligence in Diagnostics Market Growth, Size, Trends Analysis - By Component, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: HLCA25319 | Pages: 1 - 262 | Formats*: |
| Category : Healthcare | |||
Global Artificial Intelligence in Diagnostics Market Introduction and Overview
According to SPER Market Research, the Global Artificial Intelligence in Diagnostics Market is estimated to reach USD 10.24 billion by 2034 with a CAGR of 22.46%.
The report includes an in-depth analysis of the Global Artificial Intelligence in Diagnostics Market, including market size and trends, product mix, Applications, and supplier analysis. The market for Artificial Intelligence in diagnostics was valued at USD 1.35 billion in 2024 and is anticipated to grow at a compound annual growth rate (CAGR) of 22.46% from 2024 to 2032. The growing incidence of chronic diseases significantly contributes to the expansion of this market, as healthcare providers increasingly utilize AI solutions to enhance early detection, precise diagnosis, and personalized treatment plans for ailments such as diabetes and cancer, among others. The rise in chronic illnesses is driven by multiple factors, including an aging population, inactive lifestyles, and poor dietary choices, which have led to a considerable increase in the target demographic and healthcare needs.
By Component Insights
The market is categorized based on components into software, services, and hardware. In 2024, the software segment generated the highest revenue. AI diagnostics rely heavily on advanced algorithms and machine learning models that are integrated into software platforms. These platforms are designed to analyze intricate medical data, including imaging and genomic information, and deliver actionable insights, establishing software as the foundation of AI-driven diagnostics. Furthermore, software can be continuously updated and enhanced with new algorithms, features, and capabilities, enabling healthcare providers to remain at the forefront of diagnostic technology. This flexibility and scalability have become vital elements in the swift advancement of AI diagnostics.
By Application Insights
The artificial intelligence in diagnostics market is classified by application into radiology, oncology, cardiology, neurology, pathology, infectious diseases, and other applications. The radiology segment led the market, capturing a significant revenue share in 2024. Radiology entails the examination of extensive quantities of medical images, such as X-rays, CT scans, MRIs, and ultrasounds. AI tools excel in processing and interpreting these images, positioning radiology as a key area for AI integration. The capability of AI to swiftly and accurately analyze images has greatly enhanced diagnostic efficiency, resulting in widespread adoption.
By End-User Insights
In terms of end-users, the artificial intelligence in diagnostics market is divided into hospitals & clinics, diagnostic laboratories, imaging centers, and other end-users. The hospitals & clinics segment was the market leader in 2024. These facilities cater to a large and varied patient demographic, necessitating a broad spectrum of diagnostic services. AI-driven diagnostic tools are crucial in these environments to handle the substantial volume of diagnostic procedures, ranging from imaging to laboratory tests, thereby ensuring prompt and precise results.
Regional Insights
In 2024, North America emerged as the leading region in the AI in diagnostics market. Specifically, the U.S. is pioneering the adoption of advanced healthcare technologies. Healthcare providers in this region are actively seeking to integrate AI-powered diagnostic tools to enhance accuracy, minimize diagnostic errors, and improve patient outcomes. This extensive adoption is driven by a robust commitment to technological advancement and a comprehensive healthcare framework. Furthermore, the region exhibits a high prevalence of chronic illnesses, such as cardiovascular diseases, diabetes, and cancer. AI-assisted diagnostics play a vital role in the early identification and management of these conditions, thereby increasing the demand for AI solutions in the healthcare industry.
Market Competitive Landscape
The market comprises several prominent players that emphasize technological innovation and strategic alliances. Businesses are channeling investments into AI-driven analytical platforms that offer enhanced insights into disease trends and patient outcomes. Additionally, there is a growing emphasis on merging AI with current infrastructure and medical imaging capabilities to facilitate more accurate, timely, and precise results. Collaborations between technology firms and healthcare providers are also on the rise, fostering innovation and broadening the implementation of AI tools and solutions across diverse healthcare sectors.
Recent Developments:
In September 2024, Roche declared the expansion of its digital pathology platform by incorporating over 20 sophisticated AI algorithms from eight newly partnered organizations. These strategic alliances aim to bolster the capabilities of pathologists and researchers in cancer diagnosis and treatment, harnessing advanced AI technologies to enhance diagnostic efficiency and precision.
In July 2024, Microsoft joined forces with Mass General Brigham and the University of Wisconsin to refine AI models for medical imaging, thereby improving the efficiency of radiologists and resulting in better patient outcomes.
In July 2024, GE HealthCare partnered with AWS to develop AI-powered healthcare models, which streamline workflows and enhance the accuracy of diagnoses.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Component, By Application, By End-User |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Aidoc, AliveCor Inc, Digital Diagnostics, Inc, Enlitic, IBM Corporation, Imagen Technologies, NVIDIA Corporation, PathAI, RADLogics, Riverain Technologies. |
Key Topics Covered in the Report
- Global Artificial Intelligence in Diagnostics Market Size (FY’2021-FY’2034)
- Overview of Global Artificial Intelligence in Diagnostics Market
- Segmentation of Global Artificial Intelligence in Diagnostics Market By Component (Software, Services, Hardware)
- Segmentation of Global Artificial Intelligence in Diagnostics Market Application (Radiology, Oncology, Cardiology, Neurology, Pathology, Infectious Diseases)
- Segmentation of Global Artificial Intelligence in Diagnostics Market By End-User (Hospitals & Clinics, Diagnostic laboratories, Imaging Centers)
- Statistical Snap of Global Artificial Intelligence in Diagnostics Market
- Expansion Analysis of Global Artificial Intelligence in Diagnostics Market
- Problems and Obstacles in Global Artificial Intelligence in Diagnostics Market
- Competitive Landscape in the Global Artificial Intelligence in Diagnostics Market
- Details on Current Investment in Global Artificial Intelligence in Diagnostics Market
- Competitive Analysis of Global Artificial Intelligence in Diagnostics Market
- Prominent Players in the Global Artificial Intelligence in Diagnostics Market
- SWOT Analysis of Global Artificial Intelligence in Diagnostics Market
- Global Artificial Intelligence in Diagnostics Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Artificial Intelligence in Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Artificial Intelligence in Diagnostics Market
7.Global Artificial Intelligence in Diagnostics Market, By Component (USD Million) 2021-2034
7.1.Software7.2.Services7.3.Hardware
8.Global Artificial Intelligence in Diagnostics Market, By Application (USD Million) 2021-2034
8.1.Radiology8.2.Oncology8.3.Cardiology8.4.Neurology8.5.Pathology8.6.Infectious diseases8.7.Other applications
9.Global Artificial Intelligence in Diagnostics Market, By End-User (USD Million) 2021-2034
9.1.Hospitals & clinics9.2.Diagnostic laboratories9.3.Imaging centers9.4.Other end-users
10.Global Artificial Intelligence in Diagnostics Market, (USD Million) 2021-2034
10.1. Global Artificial Intelligence in Diagnostics Market Size and Market Share
11.Global Artificial Intelligence in Diagnostics Market, By Region, (USD Million) 2021-2034
11.1.Asia-Pacific
11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada11.4.2.Mexico11.4.3.United States
11.5.Latin America
11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1.Aidoc
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2.AliveCor Inc
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3.Digital Diagnostics, Inc
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4.Enlitic
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5.IBM Corporation
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6.Imagen Technologies
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7.NVIDIA Corporation
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8.PathAI
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9.RADLogics
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10.Riverain Technologies
12.10.1. Company details12.10.2. Financial outlook12.10.3 Product summary12.10.4. Recent developments
13.1.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Aidoc, AliveCor Inc, Digital Diagnostics, Inc, Enlitic, IBM Corporation, Imagen Technologies, NVIDIA Corporation, PathAI, RADLogics, Riverain Technologies.
The report includes an in-depth analysis of the Global Artificial Intelligence in Diagnostics Market, including market size and trends, product mix, Applications, and supplier analysis.
Artificial Intelligence Diagnostics Market is projected to reach USD 10.24 billion by 2034, growing at a CAGR of 22.46% during the forecast period.
Artificial Intelligence Diagnostics Market size from 2025. The Market is expected to reach USD 10.24 billion by 2034, at a CAGR of 22.46% during the forecast period.
Artificial Intelligence Diagnostics Market CAGR of 22.46% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Artificial Intelligence Diagnostics Market size is USD 10.24 billion from 2025 to 2034.
Artificial Intelligence Diagnostics Market covered By Component, By Application, By End-User
The North America is anticipated to have the highest Market share in the Artificial Intelligence Diagnostics Market.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
